HIGHLIGHTS
- What: We presented the case of an asymptomatic 43-year-old patient with triple-negative ET and AvWD who demonstrated a successful response to aspirin and hydroxyurea.
- Who: Sonal Kumar and collaborators from the Vascular Surgery, Ross University School of Medicine, Miramar, USA Hematology and Oncology, Cleveland Clinic have published the research: Review began 11/25/2024 Review ended 12/05/2024 Published 12/07/2024 © Copyright, in the Journal: (JOURNAL) of December/07,/2024
SUMMARY
Essential thrombocythemia (ET) is a myeloproliferative neoplasm (MPN) identified by persistent thrombocytosis and increased risk . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.